Related Experiment Video
Updated: Oct 9, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
COVID-19 AND PRIMARY CARE: POSSIBILITIES FOR INCREASING POSITIVE OUTCOMES
Artur V Kurakh1, Mykhaylo M Hechko1, Ivan V Chopey1
1UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE.
Insights
Patients with obesity, diabetes, COPD, cardiovascular diseases, and liver diseases face a higher risk of severe COVID-19 and death. This study identifies key non-communicable diseases impacting COVID-19 outcomes.
Area of Science:
- Medical Research
- Infectious Diseases
- Public Health
Background:
- COVID-19 (Coronavirus Disease 2019) has a significant impact on global health.
- Non-communicable diseases (NCDs) are known risk factors for various infections.
- Understanding the interplay between NCDs and COVID-19 severity is crucial for patient management.
Purpose of the Study:
- To identify prevalent non-communicable diseases associated with severe COVID-19.
- To evaluate diagnostic tools for COVID-19.
- To determine methods for predicting disease deterioration.
Main Methods:
- Systematic literature review of publications.
- Keywords: COVID-19, non-communicable disease, obesity, hypertension, comorbidities, frailty, diabetes, COPD, CVD, liver diseases, diagnostic tools, outcomes.
- Databases searched: PubMed, MEDLINE, Web of Science.
Main Results:
- Obesity, diabetes mellitus, chronic obstructive pulmonary disease (COPD), cardiovascular diseases (CVD), and liver diseases are common comorbidities.
- These NCDs are linked to an increased risk of moderate to severe COVID-19 infection.
- Diagnostic tools and prognostic indicators for COVID-19 were evaluated.
Conclusions:
- Concomitant obesity, diabetes mellitus, COPD, CVD, and liver diseases significantly elevate the risk of severe COVID-19 forms.
- Patients with these comorbidities are at higher risk of mortality from COVID-19.
- Effective diagnostic and prognostic strategies are essential for managing COVID-19 in patients with NCDs.
Objective:
The aim: Determine the most common non-communicable diseases which are associated with an increased rate of moderate and severe COVID-19 infection. Identify the best tools for diagnosing COVID-19 and predicting the deterioration of the disease.
Patients And Methods:
Materials and methods: Publications were processed and analyzed according to the keywords of the topic of work "COVID-19", "non-communicable disease", "obesity", "hypertension", "Comorbidities", "frailty", "diabetes", "chronic obstructive pulmonary disease", "cardio-vascular diseases", "liver diseases", "diagnostic tools", "outcomes" in the databases of PubMed, MEDLINE, Web of Science.
Conclusion:
Conclusions: As a result of the analysis, we found that patients with concomitant obesity, diabetes mellitus, COPD, CVD and liver diseases have an increased the risk of severe forms and death from COVID-19.
Related Concept Videos
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Preventive Healthcare Services
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Patient-centered Care
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Acute Coronary Syndrome IV: Interprofessional Care

